Clinical trial

Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.

NCT02620384

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2015-10-01

PhasePHASE3

Study timeline

Study start (actual)2015-10-01Date precision: day

Registry last updated2019-02-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Acute Decompensated Heart Failureunresolved

Interventions

Experimental: PlaceboDRUG

Experimental: MetolazoneDRUG

Sponsors & collaborators

Aultman Health Foundationlead sponsor

Mapped research locations

CantonOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02620384 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.